Brace yourselves and prepare to be inspired by four unique and inspiring personalities of the Medicine and Scientific World. Adding up to our three futuristic modules, these talks will broaden your horizons unravelling some of the most hot topics of today such as: Immunology, Healthcare Inequality and the Cure for some Deadly Chronic Diseases. You will also be able to learn from the best by witnessing a lifelong passion and dedication to science at our Nobel Lecture.
Jules Hoffmann, PhD
PhD, Nobel Laureate in Physiology or Medicine
Prof. Jules Hoffmann is a world-renowned immunologist known for winning the Nobel Prize in Medicine or Physiology in 2011. From a young age, Prof. Hoffmann had a deep interest in insect and biology. These interests led him down the scientific path, in a career filled with academic and scientific achievements, such as holding the positions of director of research for the Immune Response and Development in Insects Unit, as director for the Centre National de la Recherche Scientifique Institute of Molecular and Cellular Biology as well as president of the French National Academy of Sciences. He has also held a professorship at the University of Strasbourg. In the research, he found a keen interest in insect immunology. This interest culminated in the discovery of the Toll gene in Drosophila, which led to new discoveries in innate immunity activation and the discovery of Toll-like receptors in human immune cells. For this discovery, Prof. Hoffmann was awarded the Nobel Prize in Medicine or Physiology in 2011, along with American immunologist Bruce A. Beutler and Canadian immunologist and cell biologist Ralph M. Steinman. If we wish to set out and become discover the unknown truths in Science, it is essential that we look back to who, in our own place, succeeded in facing the unexplored. On the 18th of March, come join us in exploring the unknown with Prof. Jules Hoffmann.
Paula Johnson, MD
MD and M.P.H. from Harvard College; President of Wellesley College; Member of the American Academy of Arts and Sciences; Member of the National Academy of Medicine
A pioneer in uncovering key differences in how men and women experience heart disease and respond to its treatment, Dr. Paula Johnson is a Cardiologist and a Master in Public Health who has been a voice for advancing, promoting and defending the health and well-being of women around the globe. She has dedicated her scientific and medical career to furthering the knowledge we currently have access to on the biological differences between women and men, leadind the way in ensuring that research findings effectively translated to adequate clincal care for both sexes. Dr. Johnson is a member of the American Academy of Arts and Sciences and the National Academy of Medicine, besides being the current president of Wellesley College, the first black woman to hold this position. Before this, she was founding executive director of the Connors Center for Women’s Health and Gender Biology, chief of the Women’s Health Division at Brigham and Women’s Hospital, a professor of medicine at Harvard Medical School, and a professor of epidemiology at Harvard T.H. Chan School of Public Health. Diverse magazine has named her as one of the top “25 Women in Higher Education and Beyond”. As Dr. Paula says, “Women’s health is an equal rights issue as important as equal pay, and it’s an issue of the quality and integrity of science and medicine” and “creating a powerful movement to lift the health of women globally could transform the health of the world.”
Nezam Afdhal, MD
M.D. degree at the Royal College of Surgeons in Ireland; Chief of Hepatology and director of the Liver Center at Beth Israel Deaconess Medical Center in Boston, Massachusetts; Professor of Medicine at Harvard Medical School
A world-wide reference in Liver Disease, Chief of the Division of Gastroenterology, Hepatology and Nutrition at Beth Israel Deaconess Medical (BIDMC) since 2019 and a Professor of Medicine at Harvard Medical School, Dr. Nezam Afdhal has been a leader in the search for treatments for diseases once seen as uncurable, such as Hepatitis B and C, Liver Fibrosis and NASH and in finding global strategies for the eradication of the Hepatitis C virus. Dr. Afdhal’s contribution to the field of Hepatology, through both his clinical practice and the various clinical trials he spearheads, is undeniable. Amongst many awards, Dr. Nezam has received the American Liver Foundation Award for Excellence, a Fullbright Scholarship and an Honorary Doctor of Science from the Royal College of Surgeons in Ireland. Besides this, he has published more than 250 original papers in prestigious scientific journals and is a member of the American Gastroenterological Association, the American Association for the Study of Liver Diseases, and the European Association for the Study of the Liver.